1.3M XNAS Volume
XNAS 03 Apr, 2025 5:30 PM (EDT)
High Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
Aurinia Pharmaceuticals Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..